Jekyll and Hyde of chemotherapy treatment: Method for patient-specific dosing of chemotherapy medications.
Currently chemotherapy dosing is determined by a patient's weight, height and renal function. Dosing chemotherapy based on these parameters is generally effective, assuming all other physiological conditions are normal. In hypoalbuminaemia patients a decrease in albumin often results in more severe side-effects, since this may lead to higher chemotherapy free drug levels. A new method to dose chemotherapy based on a patients albumin will maintain the same effective free drug levels as in patients with normal albumin. This can reduce the severity of chemotherapy side-effects and may: ensure better outcomes for patients since it allows them to complete their course of chemotherapy without interruption, decrease the cost and complications associated with severe side-effects, and will allow for enhanced treatment options.